Telix Pharmaceuticals Limited (ASX: TLX)

Telix Pharmaceuticals Balance Sheet

Financials in millions AUD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	118.84	123.24	116.33	22.04	77.95	44.6
Cash & Short-Term Investments	118.84	123.24	116.33	22.04	77.95	44.6
Cash Growth	-9.79%	5.94%	427.88%	-71.73%	74.77%	73.05%
Accounts Receivable	89.33	64.78	39.35	0.73	0.16	0.75
Other Receivables	-	7.1	6.57	20.12	14.03	12.26
Receivables	89.33	71.88	45.92	20.85	14.19	13.01
Inventory	30.8	17.31	8.48	3.45	0.63	0.54
Prepaid Expenses	-	12.42	2.51	1.21	0.86	0.53
Total Current Assets	255.26	224.85	173.23	47.54	93.63	58.68
Property, Plant & Equipment	38.26	30.49	18.84	6.33	4.82	1.9
Long-Term Investments	10.46	12.26	-	-	-	-
Goodwill	117.75	4.85	5.52	4.1	4.22	4.22
Other Intangible Assets	281.74	104.82	53.47	51.63	54.97	37.72
Long-Term Deferred Tax Assets	36.7	20.45	3.97	-	-	-
Other Long-Term Assets	5.8	0.59	0.33	0.21	0.18	0.08
Total Assets	745.96	398.3	255.35	109.81	157.82	102.61
Accounts Payable	22.3	32.84	16.81	11.88	5.81	6.96
Accrued Expenses	69.86	56.04	37.12	11.67	2.49	1.37
Short-Term Debt	-	-	-	0.02	-	-
Current Portion of Long-Term Debt	1.9	0.96	-	-	0.26	0.47
Current Portion of Leases	1.88	0.6	0.64	0.61	0.5	0.02
Current Income Taxes Payable	33.97	11.51	7.32	-	-	-
Current Unearned Revenue	13.11	11.57	5.34	6.2	3.31	-
Other Current Liabilities	115.35	43.89	18.33	7.6	7.58	1.8
Total Current Liabilities	258.37	157.41	85.56	37.98	19.96	10.63
Long-Term Debt	9.95	8.21	3.31	-	0.1	0.29
Long-Term Leases	8.41	7.68	6.49	1.91	1.35	1.35
Long-Term Unearned Revenue	6.83	14.25	24.67	24.54	28.5	0.65
Long-Term Deferred Tax Liabilities	9.62	-	-	-	-	3.17
Other Long-Term Liabilities	48.35	61.52	55.1	43.09	28.91	16.44
Total Liabilities	341.98	249.39	175.35	107.66	78.81	32.53
Common Stock	587.41	446.27	370.97	170.84	167.06	115.94
Retained Earnings	-233.5	-263.67	-272.82	-173.47	-92.96	-48.07
Comprehensive Income & Other	50.07	-33.69	-18.15	4.79	4.92	2.21
Shareholders' Equity	403.97	148.91	80.01	2.16	79.02	70.08
Total Liabilities & Equity	745.96	398.3	255.35	109.81	157.82	102.61
Total Debt	22.14	17.45	10.45	2.54	2.21	2.13
Net Cash (Debt)	96.69	105.79	105.88	19.5	75.74	42.47
Net Cash Growth	-18.49%	-0.09%	443.05%	-74.26%	78.35%	76.64%
Net Cash Per Share	0.29	0.33	0.34	0.07	0.29	0.18
Filing Date Shares Outstanding	334.23	323.96	316.71	308.2	280.41	253.44
Total Common Shares Outstanding	334.23	323.73	316.34	285.07	280.41	253.28
Working Capital	-3.11	67.44	87.68	9.56	73.67	48.05
Book Value Per Share	1.21	0.46	0.25	0.01	0.28	0.28
Tangible Book Value	4.49	39.25	21.02	-53.57	19.83	28.13
Tangible Book Value Per Share	0.01	0.12	0.07	-0.19	0.07	0.11
Land	20.14	20.75	9.83	2.35	2.46	-
Machinery	8.64	2.5	1.7	1.85	0.64	0.41
Leasehold Improvements	2.68	1.91	1.54	0.38	0.23	0.22

Source: S&P Capital IQ. Standard template. Financial Sources.